Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media
More topics under "C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media" (918,689)
C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
C12N 11 - Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof (12,439)
C12N 13 - Treatment of micro-organisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves (3,958)
C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
C12N 3 - Spore-forming or isolating processes (415)
C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
11/2010
11/23/2010US7838651 nucleotide sequences comprising a Yarrowia genetic translation initiation site, for encoding desaturases
11/23/2010US7838289 Assay utilizing multipotent adult stem cells
11/23/2010CA2222140C Packaging systems for human recombinant adenovirus to be used in gene therapy
11/18/2010US20100292456 Rna interference mediating small rna molecules
11/18/2010US20100292455 MODIFIED iRNA AGENTS
11/18/2010US20100291559 Compositions of orthogonal lysyl-tRNA and aminoacyl-tRNA synthetase pairs and uses thereof
11/17/2010CN101884784A Bv8 nucleic acids and polypeptides with mitogenic activity
11/16/2010CA2422622C Novel baff-r nucleic acids and polypeptides
11/11/2010US20100286380 Pretreatment method for extraction of nucleic acid from biological samples and kits therefor
11/10/2010EP1556081B1 Recombinant intracellular pathogen immunogenic compositions and methods for use
11/09/2010US7829686 Nucleic acid encoding a subunit of Na+,K+-ATPase
11/09/2010CA2161684C Bioactive and/or targeted dendrimer conjugates
11/09/2010CA2137815C Dna sequences used in the production of recombinant human bssl/cel in transgenic non-human mammals, and the produced bssl/cel used in infant formulas
11/04/2010US20100280114 Primers and primer sets for use in methods to detect the presence of acidovorax avenae subsp. citrulli
11/04/2010US20100278728 Anti-Mullerian Inhibiting Substance Type II Receptor (MISIIR) Immunoconjugates to Detect and Treat Cancer
11/03/2010EP1261718B1 Corynebacterium glutamicum genes encoding metabolic pathway proteins
11/02/2010US7824907 Expression vectors comprising the mCMV IE2 promoter
11/02/2010US7824894 Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof
11/02/2010US7824885 Expression vector comprising pro-subtilisin nucleotide sequences for use as drug delivery system in gene therapy
10/2010
10/28/2010US20100272716 Antibodies to VLA-1
10/27/2010CN1871005B 21-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
10/26/2010US7820766 Branched acetylene-containing poly(alkylene oxides, oxyethylated polyols or olefinic alcohols)
10/26/2010US7820440 Using vector comprising early gene modifications as genetic transfer element in gene therapy; gnentic vaccines
10/26/2010US7820378 Spectrometric analysis ; splitting compound; measurement signals; calibration
10/26/2010US7820162 Methods for chemically synthesizing immunoglobulin chimeric proteins
10/21/2010US20100267005 Crosslinking Within Coordination Complexes
10/21/2010US20100266549 Novel probiotics for pet food applications
10/20/2010EP2241329A2 Anti-interleukin-9 antibody or anti-interleukin-9 receptor antibody for treating bronchial hyper-responsiveness
10/20/2010EP1633890B1 METHODS AND COMPOSITIONS FOR ENHANCING THE EFFICACY AND SPECIFICITY OF FNAi
10/19/2010CA2381489C G-csf analog compositions and methods
10/19/2010CA2366896C Method for the purification, recovery, and sporulation of cysts and oocysts
10/14/2010US20100261874 Synthetic genes for plant gums and other hydroxyproline rich glycoproteins
10/12/2010US7811984 BV8 nucleic acids and polypeptides with mitogenic activity
10/12/2010US7811801 producing a protein in a cell with a redox active amino acid at a specified position; using an orthogonal-tRNA (O-tRNA) that functions in the cell and recognizes the selector codon and an orthogonal aminoacyl-tRNA synthetase (O-RS) that aminoacylates the O-tRNA with the redox active amino acid
10/12/2010CA2419205C Anti-tnf antibodies, compositions, methods and uses
10/07/2010US20100255576 Cell culture methods and devices utilizing gas permeable materials
10/06/2010EP2236619A2 BCL2L12 polypeptide activators and inhibitors
10/06/2010CN101855232A Production of high mannose proteins in plant culture
10/05/2010US7807862 Transgenic bovine comprising human growth hormone in its serum and methods of making
10/05/2010US7807440 Ability to colonize the human vagina; bacterial vaginosis, viral vaginosis, yeast vaginitis, infections in the vagina, urinary tract infection
10/05/2010US7807345 Kit which utilizes 5' untranslated region of viral sequences as probe in detection of viral infection
09/2010
09/30/2010US20100251419 Novel nucleic acids from sesame plants
09/29/2010EP1608411B1 Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure.
09/29/2010CN1878785B Delta12 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous yeast
09/29/2010CN101843895A Cytokine receptor ZCYTOR17 multimers
09/28/2010US7803781 Modulation of growth hormone receptor expression and insulin-like growth factor expression
09/28/2010US7803598 CGTase polypeptide with increased hydrolase activity; useful in preparing a food or a food product such as bakery products
09/23/2010US20100240064 Differential enzymatic fragmentation
09/22/2010EP2230319A2 Gene expression markers for breast cancer prognosis
09/22/2010EP2230318A1 Gene expression markers for breast cancer prognosis
09/22/2010EP2230299A1 Novel cytokine ZCYTOR17 ligand
09/21/2010US7799550 for culturing a microorganism in a growth medium prepared from a sterile nutrient composition derived from the biomass of a culture of bacteria including methanotrophic bacteria; suitable for use as growth substrates for heterotrophic microorganisms
09/16/2010US20100234293 Novel Neurotrophic Factors
09/15/2010EP2228379A1 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore
09/14/2010US7795509 Tobacco products with reduced nicotine
09/14/2010US7794978 Cells comprise orthogonal aminoacyl-tRNA synthetase and p-acetyl-L-phenylalanine; site-directed mutagenesis; kits
09/14/2010US7794948 Biomarkers for alzheimer's disease
09/09/2010US20100224255 Fluid control structures in microfluidic devices
09/08/2010EP2226385A1 Human Coagulation Factor VII Variants
09/08/2010CN101824441A Production of polyunsaturated fatty acids in oleaginous yeasts
09/07/2010US7790691 A first oligonucletide and a second are complimentary and hybridize with each other to a target nucleic acid for their use in modulating gene expression; hybridize to a portion of a target RNA resulting in loss of normal function of the target RNA
09/07/2010US7790673 Methods and compositions relating to cystatin C
09/07/2010US7790385 Kits containing oligonucleotide nucleic acid that hybridizes target, with tail containing detecatble reporter and purine or pyrimidine endonuclease cleavage site attached through photodiester bonds
09/07/2010CA2412609C Methods for isolating centromere dna
09/02/2010US20100223679 Targeted and regional cellular ablation in zebrafish
09/02/2010US20100222229 Gene Expression Markers for Breast Cancer Prognosis
09/02/2010US20100221249 Wisp polypeptides and nucleic acids encoding same
08/2010
08/31/2010US7786352 Methods for the production of apolipoproteins in transgenic plants
08/31/2010US7786279 Nucleic acid molecules, polypeptides, antibodies and compositions for treating and detecting influenza virus infection
08/31/2010US7785779 Generating vector comprising regulatory sequences associated with protein translation elongation factor TU (P EF-TU); improving exogenous gene expression
08/31/2010US7785319 Method and apparatus for treating bodily tissues with medicinal substance
08/26/2010US20100218282 Nucleic acid molecules from rice controlling abiotic stress tolerance
08/26/2010US20100217534 Methods and materials for canine breed identification
08/26/2010US20100217050 For pegylation of biodrugs such as proteins; end groups etherified with acetylenic group
08/25/2010EP2221377A1 Oligonucleotide compositions with enhanced efficiency
08/25/2010EP2221315A1 Methods of generating variant proteins with increased host string content and compositions thereof
08/25/2010EP2220105A2 Production of high mannose proteins in plant culture
08/25/2010EP1649061B1 Genes as diagnostic tools for autism
08/24/2010US7781568 single chain Fv antibodies which specifically binds the extracellular domain of MISIIR; imaging cancer, particularly ovarian cancer
08/24/2010US7781161 Detection cancer; controlling gene expression; detection hybrids
08/24/2010CA2274985C Synthetic antisense oligodeoxynucleotides targeted to human acetylcholinesterase
08/19/2010US20100212032 Compositions and Methods for the Efficient and Reproducible Generation of Clone Animals of All Developmental Stages and Methods of Use Thereof
08/19/2010US20100210552 Human glucagon-like peptide-1 mimics and their use in the treatment of diabetes and related conditions
08/19/2010US20100209400 TAK1-Mediated Regulation of Osteogenesis
08/18/2010EP2218727A1 Modulation of C-reactive protein expression
08/17/2010US7776569 Identifying drug targets; assaying for expression of candidate ribonucleic acid in RNAi pathway molecule and svRNA
08/17/2010US7776338 useful for enhancing immune response to antigens; lack ganglioside binding activity; applicable to mucosal immunization in humans
08/12/2010US20100205691 Nucleotide sequences regulating gene expression and constructs and methods utilizing same
08/12/2010US20100204448 Method and carrier complexes for delivering molecules to cells
08/12/2010US20100203593 CIP1 Polypeptides and their uses
08/11/2010EP2216415A1 Compositions and methods for preparing short RNA molecules and other nucleic acids
08/11/2010EP2216342A1 Anti-CD19 antibodies
08/10/2010US7772203 Useful in the design of improved RNAi-mediating agents which allow for more exact control of the efficacy of RNA silencing; enhancing silencing of a target mRNA
08/10/2010US7771982 lactic acid bacterial micro-organisms that have been isolated and selected for their probiotic potential and their use for the preparation of petfood compositions; lactobacilli, bifidobacteria or Enterococci
08/05/2010US20100196394 Anti-cancer vaccine composition
08/04/2010EP2213741A2 Compositions and methods of using a synthetic DNAse I
08/04/2010EP2213737A1 Double-stranded oligonucleotides
08/04/2010EP2213292A1 Double-stranded oligonucleotides
08/03/2010US7767788 Folding protein functioning as a molecular switch
08/03/2010US7767454 Generating genetic aberrations in splice acceptors which have phenotypic manifestations using nonhomologous recombination with plasmids, transposons or retroviruses
1 ... 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 ... 100